Clinical Trial Update: Assessment of Quitting Versus Using Aspirin Therapy In Patients Treated With Oral Anticoagulation for Atrial Fibrillation or Other Indication With Stabilized Coronary Artery Disease [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating quitting versus continuing aspirin therapy in patients on oral anticoagulation with stabilized coronary artery disease has been termi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Coronary Artery Disease

Drugs mentioned

• Aspirin (Aspirin)

Snippet

Sponsor: University Hospital, Brest | Conditions: Coronary Artery Disease | Phase 3 | Status: TERMINATED